2) Ser/Thr protein phosphatase
丝/苏氨酸蛋白磷酸酶
1.
Using phosphothreonine polypeptide K-R-pT-I-R-R as substrate,the activities of Ser/Thr protein phosphatase(rSjPP) of Schistosoma japonicum expressed in Escherichia coli were tested.
分别以磷酸苏氨酸多肽(K-R-pT-I-R-R)和4-硝基苯基磷基二钠盐(pNPP)为底物,研究原核表达的日本血吸虫丝/苏氨酸蛋白磷酸酶重组蛋白rSjPP的酶活性,检测二价金属阳离子(Mn2+、Ni2+、Mg2+、a2+)、温度、pH值对rSjPP酶活性的影响。
3) Phospho-serine/threonine protein kinase
磷酸化丝氨酸/苏氨酸蛋白激酶
4) Ser/Thr protein phosphatase inhibitory activity
丝氨酸苏氨酸蛋白质磷酸酶抑制活性
5) serine-threonine specific protein phosphatase
丝氨酸-苏氨酸蛋白磷酸酶
1.
Expression and protective immunity of serine-threonine specific protein phosphatase SjPP of Schistosoma japonicum;
日本血吸虫丝氨酸-苏氨酸蛋白磷酸酶基因的表达及其免疫保护试验
6) Akt
丝氨酸/苏氨酸蛋白激酶
1.
Objective To observe the changes of Akt1,Akt2,Akt3 mRNA expression level in rat pulmonary arterial smooth muscle cells(PASMC) induced by hypoxia and to investigate the value of Akt signaling pathway in vascular reconstruction during phyoxia pulmonary hypertension(HPH).
目的通过观察缺氧致大鼠肺动脉平滑肌细胞(pu lmonary arterial smooth musc le cell,PASMC)3种丝氨酸/苏氨酸蛋白激酶(Akt1、Akt2、Akt3)mRNA的表达水平变化,初步探讨Akt信号途径在缺氧肺动脉高压(hypoxia pu lmonaryhypertension,HPH)血管重建中的作用。
2.
Objective To observe the changes of Akt3 mRNA and protein expressive level in pulmonary arterial smooth muscle cells(PASMC)induced by hypoxia in rats,and to investigate the regulatory role of Akt3 signaling pathway in hypoxia-induced pulmonary vascular remodeling.
目的通过观察缺氧致大鼠肺动脉平滑肌细胞(PASMC)丝氨酸/苏氨酸蛋白激酶3(Akt3)mRNA及其蛋白表达水平变化与低氧PASMC增殖的关系,探讨Akt3在低氧肺血管重建中的调控作用。
3.
Objective To investigate the regulating effects of PI3-K/Akt signaling pathway on the differentiation of the marrow-derived cardiac stem cells(MCSCs) induced with BMP-2 toward cardiomyocytes and to determine the possible mechanisms in signal transduction on differentiation of MCSCs toward cardiomyocytes.
目的研究磷脂酰肌醇-3激酶/丝氨酸/苏氨酸蛋白激酶(PI3-K/Akt)信号通路在骨形态发生蛋白-2(BMP-2)诱导骨髓源性心肌干细胞(MCSCs)向心肌细胞分化中的调控作用,探讨MCSCs向心肌细胞分化的信号转导机制。
补充资料：磷酸伯氨喹啉
分子式：暂无
分子量：暂无
CAS号：63-45-6
性质：暂无
制备方法：暂无
用途：抗疟药，用于控制间日疟与三日疟的复发和恶性疟的传播。
分子量：暂无
CAS号：63-45-6
性质：暂无
制备方法：暂无
用途：抗疟药，用于控制间日疟与三日疟的复发和恶性疟的传播。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条